Local levonorgestrel to prevent tamoxifen-related endometrial lesions

Lancet. 2000 Nov 18;356(9243):1698-9. doi: 10.1016/S0140-6736(00)03197-4.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents, Hormonal / adverse effects*
  • Antineoplastic Agents, Hormonal / therapeutic use
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / pathology
  • Endometrium / drug effects*
  • Endometrium / pathology
  • Female
  • Humans
  • Intrauterine Devices, Medicated*
  • Levonorgestrel / administration & dosage*
  • Tamoxifen / adverse effects*
  • Tamoxifen / therapeutic use
  • Uterine Hemorrhage / chemically induced
  • Uterine Hemorrhage / prevention & control

Substances

  • Antineoplastic Agents, Hormonal
  • Tamoxifen
  • Levonorgestrel